Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
T Miwa, S Tajirika, N Imamura, M Adachi, R Horita… - JGH …, 2024 - Wiley Online Library
Aims The application of indices in the context of metabolic dysfunction‐associated steatotic
liver disease (MASLD) remains unexplored. We aimed to validate the ability of alanine …
liver disease (MASLD) remains unexplored. We aimed to validate the ability of alanine …
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B
N Tamaki, M Higuchi, T Keitoku, Y Yamazaki… - JGH …, 2024 - Wiley Online Library
Abstract Background and Aim Magnetic resonance elastography (MRE) is used for the
evaluation of liver fibrosis; however, it remains unclear whether MRE‐based liver stiffness is …
evaluation of liver fibrosis; however, it remains unclear whether MRE‐based liver stiffness is …
[HTML][HTML] Modified FIB-4 Index in Type 2 Diabetes Mellitus with Steatosis: A Non-Linear Predictive Model for Advanced Hepatic Fibrosis
J Kim, T Ito, T Arai, M Atsukawa, M Kawanaka… - Diagnostics, 2024 - mdpi.com
Background: The Fibrosis-4 (FIB-4) index is widely recommended as a first-tier method for
screening advanced hepatic fibrosis; however, its diagnostic performance is known to be …
screening advanced hepatic fibrosis; however, its diagnostic performance is known to be …
Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
JH Oh, DW Jun - Gut and Liver, 2024 - pmc.ncbi.nlm.nih.gov
Gut and Liver, Vol. 18, No. 2, March 2024 198 www. gutnliver. org fibrosis using serological
biomarkers like M2BPGi and Enhanced Liver Fibrosis score are pivotal for the current FIB-4 …
biomarkers like M2BPGi and Enhanced Liver Fibrosis score are pivotal for the current FIB-4 …